NeoImmuneTech, Inc. (KOSDAQ:950220)

NeoImmuneTech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	57,817	34,172	68,739	115,630	154,250	71,217
Short-Term Investments	13,617	663.25	333.38	1,445	220.29	0.9
Cash & Short-Term Investments	71,434	34,835	69,072	117,075	154,471	71,218
Cash Growth	76.51%	-49.57%	-41.00%	-24.21%	116.90%	-34.08%
Accounts Receivable	12.13	20.37	-	-	-	-
Receivables	12.13	20.37	-	-	-	-
Prepaid Expenses	2,779	4,446	-	895.8	-	-
Other Current Assets	-	33.87	3,185	-0	12,252	9,414
Total Current Assets	74,225	39,335	72,257	117,971	166,722	80,632
Property, Plant & Equipment	4,720	6,771	7,749	9,397	9,056	4,058
Other Intangible Assets	8,519	6,461	6,168	6,554	6,591	6,471
Other Long-Term Assets	919.71	12,858	4,338	5,944	4,659	4,484
Total Assets	88,384	65,426	90,511	139,865	187,027	95,645
Accrued Expenses	5,289	6,316	7,717	12,945	17,426	7,493
Short-Term Debt	8,477	6,935	-	-	-	-
Current Portion of Leases	913.63	1,150	1,353	1,279	1,284	545.01
Current Income Taxes Payable	-60.32	-	-	92.49	59.33	21.63
Other Current Liabilities	5,850	6,385	3,816	2,080	1,642	938.61
Total Current Liabilities	20,470	20,785	12,886	16,397	20,411	8,998
Long-Term Leases	2,119	2,686	2,555	3,572	4,511	2,360
Pension & Post-Retirement Benefits	177.78	257.11	151.69	142.43	-	59.45
Other Long-Term Liabilities	45.62	36.29	62.24	64.34	63.09	0
Total Liabilities	22,813	23,764	15,655	20,176	24,985	11,418
Common Stock	4.61	2.91	2.55	2.51	2.34	1.8
Additional Paid-In Capital	368,628	337,199	295,772	290,644	271,282	142,448
Retained Earnings	-331,173	-325,185	-246,517	-190,424	-122,781	-62,771
Comprehensive Income & Other	28,111	29,645	25,599	19,466	13,539	4,547
Shareholders' Equity	65,571	41,662	74,856	119,689	162,042	84,227
Total Liabilities & Equity	88,384	65,426	90,511	139,865	187,027	95,645
Total Debt	11,510	10,771	3,908	4,851	5,795	2,905
Net Cash (Debt)	59,924	24,064	65,164	112,224	148,676	68,312
Net Cash Growth	65.17%	-63.07%	-41.93%	-24.52%	117.64%	-35.08%
Net Cash Per Share	187.36	243.40	659.23	1136.26	1560.75	826.59
Filing Date Shares Outstanding	108.36	494.34	494.34	494.14	492.91	413.63
Total Common Shares Outstanding	108.36	494.34	494.34	494.14	492.91	413.63
Working Capital	53,755	18,550	59,371	101,574	146,311	71,633
Book Value Per Share	605.13	84.28	151.43	242.22	328.75	203.63
Tangible Book Value	57,052	35,200	68,689	113,136	155,452	77,756
Tangible Book Value Per Share	526.51	71.21	138.95	228.96	315.38	187.99
Machinery	4,510	6,530	5,727	4,864	3,027	1,307
Construction In Progress	-	-	-	-	764.66	46.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.